Why is Akums Drugs falling/rising?

As of 27-Jun, Akums Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at 593.35, reflecting a rise of 7.85 or 1.34%. The stock has shown strong performance recently, gaining 10.99% over the last four days and outperforming its sector by 0.46% today. Additionally, the stock's delivery volume has increased by 14.59% compared to the five-day average, indicating rising investor participation. The company has reported positive financial results, including the highest quarterly net sales and profit after tax, which have contributed to an attractive valuation with a low debt-to-equity ratio.
In the broader market context, Akums Drugs has outperformed the benchmark Sensex over the past week, with a return of 9.35% compared to the Sensex's 2.00%. However, the stock has underperformed year-to-date, showing a decline of 7.01% against the Sensex's gain of 7.58%. Despite this, the recent positive momentum and strong financial performance may indicate a potential recovery phase for the stock, as it continues to attract investor interest.